We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

67 hedge funds and large institutions have $33.6M invested in Applied Genetic Technologies Corporation in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more call options, than puts

Call options by funds: $188K | Put options by funds: $107K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less funds holding

Funds holding: 7767 (-10)

29% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 24

33% less capital invested

Capital invested by funds: $50.3M → $33.6M (-$16.7M)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
67
Holders Change
-10
Holders Change %
-12.99%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
17
Reduced
24
Closed
17
Calls
$188K
Puts
$107K
Net Calls
+$81K
Net Calls Change
+$3K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of Montreal
26
Bank of Montreal
Ontario, Canada
$230K -$5.95K -1,296 -2%
American Century Companies
27
American Century Companies
Missouri
$222K
Bank of New York Mellon
28
Bank of New York Mellon
New York
$196K -$2.08K -452 -0.9%
PAM
29
Panagora Asset Management
Massachusetts
$195K +$227K +49,402 +126,672%
SIM
30
Spark Investment Management
New York
$191K +$223K +48,500 New
Bank of America
31
Bank of America
North Carolina
$190K -$19.2K -4,183 -8%
Two Sigma Investments
32
Two Sigma Investments
New York
$185K +$118K +25,695 +121%
Squarepoint
33
Squarepoint
New York
$181K +$101K +22,089 +94%
Citadel Advisors
34
Citadel Advisors
Florida
$163K +$190K +41,270 New
MCM
35
Matarin Capital Management
New York
$143K +$166K +36,227 New
NCCM
36
Nine Chapters Capital Management
New Jersey
$113K +$131K +28,500 New
FDCDDQ
37
Federation des caisses Desjardins du Quebec
Quebec, Canada
$104K
Northern Trust
38
Northern Trust
Illinois
$84K -$367 -80 -0.4%
AA
39
Ancora Advisors
Ohio
$79K +$91.8K +20,000 New
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$71K
PP
41
PDT Partners
New York
$67K -$73.6K -16,019 -48%
Invesco
42
Invesco
Georgia
$67K
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$65K -$282K -61,432 -79%
PCM
44
Prelude Capital Management
New York
$63K +$36.3K +7,900 +99%
Tudor Investment Corp
45
Tudor Investment Corp
Connecticut
$59K +$11.9K +2,588 +21%
SGAM
46
Smith Group Asset Management
Texas
$52K -$4.36K -950 -7%
ARTA
47
A.R.T. Advisors
New York
$49K -$196K -42,656 -77%
EA
48
Emerald Advisers
Pennsylvania
$43K
Barclays
49
Barclays
United Kingdom
$41K -$105K -22,873 -69%
WS
50
Wedbush Securities
California
$40K +$46.8K +10,190 New

AGTC Hedge Fund Activity: Q3 2017 in Review

67 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2017, worth a combined $33.6M — down 33% from $50.3M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of AGTC and 8 opened new positions — a net loss of 9 holders — while 24 trimmed existing stakes and 17 added.

The largest buyer was Dimensional Fund Advisors, adding an estimated $588K. The largest seller was Millennium Management, cutting an estimated $1.42M.

  • 67 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2017, down from 77 in Q2 2017.
  • Funds reported $33.6M of Applied Genetic Technologies Corporation stock for Q3 2017, down 33% quarter-over-quarter.
  • 8 funds opened new Applied Genetic Technologies Corporation positions in Q3 2017 and 17 closed out, a net change of -9 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q3 2017 was Dimensional Fund Advisors, an estimated $588K added.
  • The largest Applied Genetic Technologies Corporation seller in Q3 2017 was Millennium Management, an estimated $1.42M sold.

Based on aggregated 13F filings for Q3 2017.